NFID Survey Revealed Confusion Over Vaccine Guidelines

A new survey found that many U.S. adults are unsure about whether respiratory virus vaccinations are recommended for them.

Updated on Sept. 28, 2026 in COVID-19

Bold vector editorial illustration of a stylized medical shield in teal and sage, representing clear health guidance. — A recent survey from the National Foundation for Infectious Diseases found widespread public confusion regarding U.S. vaccination guidelines for flu and COVID-19. AI Illustration. Upload story photo >

Live Poll

Do you feel confident knowing which vaccine recommendations apply to your own health?

The National Foundation for Infectious Diseases has released survey results indicating widespread confusion among adults regarding vaccine recommendations for flu and COVID-19. In response, the organization launched the Tame It public service campaign to provide clearer resources to the public.

Why it matters

The findings suggest that many Americans underestimate the severity of respiratory illnesses, contributing to gaps in vaccination coverage. Addressing this confusion is vital for public health, as nearly half of adults do not realize COVID-19 vaccination is recommended for them.

A survey conducted in August 2026 revealed that 28% of adults are unsure if flu vaccination is recommended for them, while 48% reported seeking a respiratory vaccine in the last year. The survey findings carry a margin of error of 3.6 percentage points.

The players

National Foundation for Infectious Diseases

This is a non-profit organization dedicated to educating the public and healthcare professionals about the burden and prevention of infectious diseases.

Centers for Disease Control and Prevention

This is the national public health agency of the United States that provides scientific guidance and data on disease prevention and health initiatives.

The details

The survey results highlight a significant disconnect between official health guidance and public perception regarding respiratory virus prevention. The Tame It initiative now distributes materials formerly part of the federal Wild to Mild campaign to help educate schools and healthcare providers.

The CDC's Wild to Mild campaign began in 2023.
There were 710,000 estimated flu-related hospitalizations during the 2024-2025 season.
The Trump administration ended the Wild to Mild campaign in February 2025.
The National Foundation for Infectious Diseases conducted the survey in August 2026.
Survey results were released on September 28, 2026.

Asthma
Sept. 24
Respiratory Vaccine Initiative Has Been Launched
COVID-19
Sept. 18
Medical Groups Issued Influenza Vaccine Recommendations
COVID-19
Sept. 25
CDC Recommended COVID-19 Vaccines for Most Ages

The Big Picture

This initiative follows the structure of the CDC's Wild to Mild campaign, which provided public health guidance until it was shuttered in early 2025. By repurposing these materials, the new effort attempts to maintain continuity in public health education despite the end of the previous federal program.

For many, this news clarifies that respiratory vaccination recommendations remain active despite the closure of previous government campaigns. Residents are encouraged to consult with healthcare providers to determine their specific eligibility and vaccination needs.

The takeaway

Understanding the actual risk of respiratory illnesses is essential for making informed personal health decisions. If you are uncertain about your vaccination status, reaching out to your primary care physician is the most reliable way to receive updated guidance.